<code id='E992A834BE'></code><style id='E992A834BE'></style>
    • <acronym id='E992A834BE'></acronym>
      <center id='E992A834BE'><center id='E992A834BE'><tfoot id='E992A834BE'></tfoot></center><abbr id='E992A834BE'><dir id='E992A834BE'><tfoot id='E992A834BE'></tfoot><noframes id='E992A834BE'>

    • <optgroup id='E992A834BE'><strike id='E992A834BE'><sup id='E992A834BE'></sup></strike><code id='E992A834BE'></code></optgroup>
        1. <b id='E992A834BE'><label id='E992A834BE'><select id='E992A834BE'><dt id='E992A834BE'><span id='E992A834BE'></span></dt></select></label></b><u id='E992A834BE'></u>
          <i id='E992A834BE'><strike id='E992A834BE'><tt id='E992A834BE'><pre id='E992A834BE'></pre></tt></strike></i>

          explore

          explore

          author:entertainment    Page View:61673
          Adam Feuerstein, upper left, moderated a panel with, clockwise, David Chang of Allogene Therapeutics, Rachel Haurwitz of Caribou Biosciences, and Lynelle Hoch of Bristol Myers Squibb. STAT

          If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future is bright. And that future will also look markedly different than it does today, three of them said at the STAT 2023 Future Summit on Wednesday.

          Now in its second decade, the cell therapy — which attacks cancer by extracting white blood cells from a patient, genetically modifying them, and then re-infusing them to fight the cancer — has made remarkable strides. Biotech reporter Adam Feuerstein reminded panelists that Emily Whitehead, the first pediatric patient to receive the therapy at age 10, has just started college.

          advertisement

          But for all its success in changing the lives of up to 7,000 patients to the point one can use the word “cure,” the field has been hampered by wait lists at manufacturers making these patient-specific, autologous therapies and a shortage of medical centers to administer them. Patients bear a burden, too: Training their B cells to attack their tumors requires an onerous depletion process before their cells can be taken out of their bodies.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
          Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

          1:19Ademonstratorrunsonthethirdnightofprotestssparkedbythefatalpoliceshootingofa17-year-olddriverint

          read more
          Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable
          Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

          CTscansshowedthatthepatientinitiallyrespondedtolorlatinib(left).Buteightmonthslater,themetastaticliv

          read more
          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more

          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport